Literature DB >> 15146016

Sporadic inclusion body myositis: morphology, regeneration, and cytoskeletal structure of muscle fibres.

S Arnardottir1, K Borg, T Ansved.   

Abstract

OBJECTIVE: To characterise morphological abnormalities in relation to muscle fibre type in sporadic inclusion body myositis (s-IBM).
METHODS: 14 muscle biopsies from 11 patients with s-IBM were characterised for morphological abnormalities and fibre type composition as well as muscle fibre regeneration and cytoskeletal structure, using histochemical and immunohistochemical techniques.
RESULTS: Morphological abnormalities included inflammatory infiltrates and "rimmed vacuoles," and pronounced variation in fibre size. There were no significant differences in fibre type composition between s-IBM patients and controls based on the myofibrillar ATPase staining. A differential effect on muscle fibre sizes was noted, type II fibres being smaller in the s-IBM patients than in the controls. Conversely, the mean type I muscle fibre diameter in the s-IBM patients was larger than in the controls, though this difference was not significant. An ongoing intense regeneration process was present in s-IBM muscle, as indicated by the expression of neonatal myosin heavy chain, vimentin, and CD56 (Leu-19) in most of the muscle fibres. The cytoskeletal proteins dystrophin and desmin were normally expressed in s-IBM muscle fibres that were not undergoing degeneration or regeneration.
CONCLUSIONS: There are extensive morphological and morphometric alterations in s-IBM, affecting different muscle fibre types in different ways. The cytoskeletal structure of type I and II muscle fibres remains unaffected in different stages of the disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15146016      PMCID: PMC1739056          DOI: 10.1136/jnnp.2003.018994

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  12 in total

1.  Foxo/atrogin induction in human and experimental myositis.

Authors:  Han-Kyu Lee; Edward Rocnik; Qinghao Fu; Bumsup Kwon; Ling Zeng; Kenneth Walsh; Henry Querfurth
Journal:  Neurobiol Dis       Date:  2012-05       Impact factor: 5.996

2.  Nitric oxide synthase in human skeletal muscles related to defined fibre types.

Authors:  Karla Punkt; Matthias Fritzsche; Christoph Stockmar; Pierre Hepp; Christoph Josten; Maren Wellner; Stefan Schering; Igor B Buchwalow
Journal:  Histochem Cell Biol       Date:  2005-11-16       Impact factor: 4.304

3.  Fast-twitch sarcomeric and glycolytic enzyme protein loss in inclusion body myositis.

Authors:  Kenneth C Parker; Sek Won Kong; Ronan J Walsh; Mohammad Salajegheh; Behzad Moghadaszadeh; Anthony A Amato; Remedios Nazareno; Yin Yin Lin; Bryan Krastins; David A Sarracino; Alan H Beggs; Jack L Pinkus; Steven A Greenberg
Journal:  Muscle Nerve       Date:  2009-06       Impact factor: 3.217

4.  Muscle wasting induced by HTLV-1 tax-1 protein: an in vitro and in vivo study.

Authors:  Simona Ozden; Vincent Mouly; Marie-Christine Prevost; Antoine Gessain; Gillian Butler-Browne; Pierre-Emmanuel Ceccaldi
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

5.  Investigation of splicing changes and post-translational processing of LMNA in sporadic inclusion body myositis.

Authors:  Yue-Bei Luo; Chalermchai Mitrpant; Russell Johnsen; Vicki Fabian; Merrilee Needham; Sue Fletcher; Steve D Wilton; Frank L Mastaglia
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

6.  An injectable liposome for sustained release of tanshinone IIA to the treatment of acute blunt muscle injury by augmenting autophagy and alleviating oxidative stress.

Authors:  Jinwu Wang; Jie Cai; Xingyu Wang; Gaosheng Zhu; Yongzeng Feng; Hua Chen; Leyi Cai
Journal:  Am J Transl Res       Date:  2020-08-15       Impact factor: 4.060

7.  Expression of myogenic regulatory factors and myo-endothelial remodeling in sporadic inclusion body myositis.

Authors:  Julia V Wanschitz; Odile Dubourg; Emmanuelle Lacene; Michael B Fischer; Romana Höftberger; Herbert Budka; Norma B Romero; Bruno Eymard; Serge Herson; Gillian S Butler-Browne; Thomas Voit; Olivier Benveniste
Journal:  Neuromuscul Disord       Date:  2012-10-09       Impact factor: 4.296

8.  The proteomic profile of hereditary inclusion body myopathy.

Authors:  Ilan Sela; Irit Milman Krentsis; Zipora Shlomai; Menachem Sadeh; Ron Dabby; Zohar Argov; Hannah Ben-Bassat; Stella Mitrani-Rosenbaum
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

9.  The injury-induced myokine insulin-like 6 is protective in experimental autoimmune myositis.

Authors:  Ling Zeng; Sonomi Maruyama; Kazuto Nakamura; Jennifer L Parker-Duffen; Ibrahim M Adham; Xuemei Zhong; Han-Kyu Lee; Henry Querfurth; Kenneth Walsh
Journal:  Skelet Muscle       Date:  2014-08-04       Impact factor: 4.912

10.  Physiological role of receptor activator nuclear factor-kB (RANK) in denervation-induced muscle atrophy and dysfunction.

Authors:  Sébastien S Dufresne; Antoine Boulanger-Piette; Sabrina Bossé; Jérôme Frenette
Journal:  Receptors Clin Investig       Date:  2016-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.